Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 133701 - 133720 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01FD03) trastuzumab emtansine | KADCYLA | 100MG, 100MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FD03) trastuzumab emtansine | KADCYLA | 160MG, 160MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FD04) trastuzumab deruxtecan | ENHERTU | 100MG, 100MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DaiichiSankyoEuropeGmbH,Mnichov |
| Czech Republic | (L01FE02) panitumumab | VECTIBIX | 20MG/ML, 20MG/ML INF CNC SOL 1X5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V.,Breda |
| Czech Republic | (L01FF02) pembrolizumab | KEYTRUDA | 25MG/ML, 25MG/ML INF CNC SOL 1X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms | MerckSharp&DohmeB.V.,Haarlem |
| Czech Republic | (L01FF03) durvalumab | IMFINZI | 50MG/ML, 50MG/ML INF CNC SOL 1X2,4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Södertälje |
| Czech Republic | (L01FF03) durvalumab | IMFINZI | 50MG/ML, 50MG/ML INF CNC SOL 1X10ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Södertälje |
| Czech Republic | (L01FF05) atezolizumab | TECENTRIQ | 1200MG, 1200MG INF CNC SOL 1X20ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FF05) atezolizumab | TECENTRIQ | 840MG, 840MG INF CNC SOL 1X14ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FF06) cemiplimab | LIBTAYO | 350MG, 350MG INF CNC SOL 1X7ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronIrelandDesignatedActivityCompany,Dublin |
| Czech Republic | (L01FG01) bevacizumab | ABEVMY | 25MG/ML, 25MG/ML INF CNC SOL 1X16ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLimited,Dublin |
| Czech Republic | (L01FG01) bevacizumab | ABEVMY | 25MG/ML, 25MG/ML INF CNC SOL 1X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLimited,Dublin |
| Czech Republic | (L01FG01) bevacizumab | ALYMSYS | 25MG/ML, 25MG/ML INF CNC SOL 1X16ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MabxienceResearchSL,Madrid |
| Czech Republic | (L01FG01) bevacizumab | ALYMSYS | 25MG/ML, 25MG/ML INF CNC SOL 1X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MabxienceResearchSL,Madrid |
| Czech Republic | (L01FG01) bevacizumab | AVASTIN | 25MG/ML, 25MG/ML INF CNC SOL 1X16ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FG01) bevacizumab | AVASTIN | 25MG/ML, 25MG/ML INF CNC SOL 1X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01FG01) bevacizumab | MVASI | 25MG/ML, 25MG/ML INF CNC SOL 1X16ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms | AmgenTechnology(Ireland)UnlimitedCompany,Dublin |
| Czech Republic | (L01FG01) bevacizumab | MVASI | 25MG/ML, 25MG/ML INF CNC SOL 1X4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms | AmgenTechnology(Ireland)UnlimitedCompany,Dublin |
| Czech Republic | (L01FG01) bevacizumab | OYAVAS | 25MG/ML, 25MG/ML INF CNC SOL 1X16ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | STADAArzneimittelAG,BadVilbel |
| Czech Republic | (L01FG01) bevacizumab | OYAVAS | 25MG/ML, 25MG/ML INF CNC SOL 1X4ML , VIA | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | STADAArzneimittelAG,BadVilbel |
Pages
